Reversible deficits in apical transporter trafficking associated with DGAT1 deficiency:
暂无分享,去创建一个
Xianlin Han | S. Levy | B. Boone | Miao Wang | L. Lapierre | J. Goldenring | Janice A. Williams | I. Kaji | H. Correa | Victoria G. Weis | Angela L. Jones | Nripesh Prasad | S. Acra | C. Pinzon-Guzman | Cameron Schlegel | K. Thomsen
[1] Xianlin Han,et al. Reversible deficits in apical transporter trafficking associated with deficiency in diacylglycerol acyltransferase , 2018, Traffic.
[2] R. Houwen,et al. Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency , 2018, Gastroenterology.
[3] T. Gilmore,et al. Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans. , 2017, Journal of medicinal chemistry.
[4] Xianlin Han,et al. Lipidomics: Comprehensive Mass Spectrometry of Lipids , 2016 .
[5] W. Gahl,et al. Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutations , 2016, European Journal of Human Genetics.
[6] Joseph T. Roland,et al. Loss of MYO5B in Mice Recapitulates Microvillus Inclusion Disease and Reveals an Apical Trafficking Pathway Distinct to Neonatal Duodenum , 2015, Cellular and molecular gastroenterology and hepatology.
[7] H. Clevers,et al. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking , 2015, Proceedings of the National Academy of Sciences.
[8] Joseph T. Roland,et al. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease. , 2014, The Journal of clinical investigation.
[9] M. Donowitz,et al. Lysophosphatidic acid stimulation of NHE3 exocytosis in polarized epithelial cells occurs with release from NHERF2 via ERK-PLC-PKCδ signaling. , 2014, American journal of physiology. Cell physiology.
[10] H. Tornqvist,et al. Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial , 2014, Diabetes, obesity & metabolism.
[11] Xianlin Han,et al. Characterization and quantification of diacylglycerol species in biological extracts after one-step derivatization: a shotgun lipidomics approach. , 2014, Analytical chemistry.
[12] S. Watkins,et al. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[13] Robert V Farese,et al. DGAT1 mutation is linked to a congenital diarrheal disorder. , 2012, The Journal of clinical investigation.
[14] G. Castaldo,et al. Congenital Diarrheal Disorders: An Updated Diagnostic Approach , 2012, International journal of molecular sciences.
[15] Jason I. Herschkowitz,et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo , 2011, Proceedings of the National Academy of Sciences.
[16] R. Berni Canani,et al. Diarrhea in neonatal intensive care unit. , 2010, World journal of gastroenterology.
[17] G. Castaldo,et al. Congenital Diarrheal Disorders: Improved Understanding of Gene Defects Is Leading to Advances in Intestinal Physiology and Clinical Management , 2010, Journal of pediatric gastroenterology and nutrition.
[18] Xianlin Han,et al. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. , 2009, Analytical chemistry.
[19] Robert V Farese,et al. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. , 2008, Journal of lipid research.
[20] Xianlin Han,et al. Microfluidics-based electrospray ionization enhances the intrasource separation of lipid classes and extends identification of individual molecular species through multi-dimensional mass spectrometry: development of an automated high-throughput platform for shotgun lipidomics. , 2008, Rapid communications in mass spectrometry : RCM.
[21] Robert V Farese,et al. Atvb in Focus Novel Approaches to the Treatment of Dyslipidemia Inhibition of Triglyceride Synthesis as a Treatment Strategy for Obesity Lessons from Dgat1-deficient Mice Dgat Enzymes and Triglyceride Synthesis , 2022 .
[22] Robert V Farese,et al. Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice* , 2004, Journal of Biological Chemistry.
[23] Robert V Farese,et al. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1. , 2002, The Journal of clinical investigation.
[24] Robert V Farese,et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat , 2000, Nature Genetics.
[25] M. Mooseker,et al. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. , 1992, Journal of cell science.